Ferrannini, Eleuterio
University of Pisa · Istituto di Fisiologia Clinica
15 papers on CoChat
Most cited papers
- Verified
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine
Diabetes, Cardiovascular Risks, and LipoproteinsBlood Pressure and Hypertension Studies
Cited by 2,344
- Verified
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care
Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 2,085
- Verified
Effect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation
Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 1,050
- Verified
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia
Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 770
- Verified
Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake
DeFronzo, R. A., Ferrannini, E., & Simonson, D. C. (1989) · Metabolism
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research
Cited by 515
- Verified
The Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative Study
Ferrannini, E., Bjorkman, O., Reichard, G. A., Pilo, A., Olsson, M., Wahren, J., & DeFronzo, R. A. (1985) · Diabetes
Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 439
- Verified
Improved Glycemic Control and Enhanced Insulin Sensitivity in Type 2 Diabetic Subjects Treated With Pioglitazone
Miyazaki, Y., Mahankali, A., Matsuda, M., Glass, L., Mahankali, S., Ferrannini, E., Cusi, K., Mandarino, L. J., & DeFronzo, R. A. (2001) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsLipid metabolism and disorders
Cited by 407
- Verified
Effect of Levothyroxine Replacement on Lipid Profile and Intima-Media Thickness in Subclinical Hypothyroidism: A Double-Blind, Placebo- Controlled Study
Monzani, F., Caraccio, N., Kozàkowà, M., Dardano, A., Vittone, F., Virdis, A., Taddei, S., Palombo, C., & Ferrannini, E. (2004) · The Journal of Clinical Endocrinology & Metabolism
Thyroid Disorders and TreatmentsCardiovascular Health and Disease Prevention
Cited by 399
- Verified
Identification of Individuals With Insulin Resistance Using Routine Clinical Measurements
Stern, S. E., Williams, K., Ferrannini, E., DeFronzo, R. A., Bogardus, C., & Stern, M. P. (2005) · Diabetes
Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases
Cited by 384
- Verified
Insulin action and age. European Group for the Study of Insulin Resistance (EGIR)
Ferrannini, E., Vichi, S., Beck-Nielsen, H., Laakso, M., Paolisso, G., & Smith, U. (1996) · Diabetes
Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes
Cited by 340
- Verified
The Role of Free Fatty Acid Metabolism in the Pathogenesis of Insulin Resistance in Obesity and Noninsulin-Dependent Diabetes Mellitus*
GROOP, L. C., SALORANTA, C., SHANK, M., BONADONNA, R. C., FERRANNINI, E., & DEFRONZO, R. A. (1991) · The Journal of Clinical Endocrinology & Metabolism
Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases
Cited by 312
- Verified
The disposal of an oral glucose load in patients with non-insulin-dependent diabetes
Ferrannini, E., Simonson, D. C., Katz, L. D., Reichard, G., Bevilacqua, S., Barrett, E. J., Olsson, M., & DeFronzo, R. A. (1988) · Metabolism
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research
Cited by 305
- Verified
The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents
Gulli, G., Ferrannini, E., Stern, M., Haffner, S., & DeFronzo, R. A. (1992) · Diabetes
Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 283
- Verified
Roles of Glucose Transport and Glucose Phosphorylation in Muscle Insulin Resistance of NIDDM
Bonadonna, R. C., Bonora, E., Prato, S. D., Saccomani, M. P., Cobelli, C., Natali, A., Frascerra, S., Pecori, N., Ferrannini, E., Bier, D., et al. (1996) · Diabetes
Metabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 191
- Verified
Regulation of hepatic glucose metabolism in humans
DeFronzo, R. A., & Ferrannini, E. (1987) · Diabetes/Metabolism Reviews
Pancreatic function and diabetesMetabolism, Diabetes, and Cancer
Cited by 167
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free